N-(2,6-Dimethylphenyl)-2-piperazin-1-ylacetamide

We are N-(2,6-Dimethylphenyl)-2-piperazin-1-ylacetamide CAS:5294-61-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:N-(2,6-Dimethylphenyl)-2-piperazin-1-ylacetamide
CAS.NO:5294-61-1
Synonyms:N-(2,6-Dimethylphenyl)-2-piperazin-1-ylacetamide
N-(2,6-Dimethylphenyl)-2-(piperazin-1-yl)acetamide
N-(2,6-Dimethylphenyl)-1-piperazineacetamide
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 411.2±45.0 °C at 760 mmHg
Melting Point 110-112ºC
Molecular Formula C14H21N3O
Molecular Weight 247.336
Flash Point 202.5±28.7 °C
 
Specification:
Appearance:Off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Ranolazine(CAS:95635-55-5).

N-(2,6-Dimethylphenyl)-2-piperazin-1-ylacetamide


Related News: Factors that have a significant impact on the sales volume of APIs come from the production side, which mainly includes costs and processes.Bis(pinacolato)diboron CAS:73183-34-3 The purpose of APIs according to the FDA is to cause ‘pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body.5-fluoro-2-metilbenzaldehído CAS:22062-53-9 Raw material drug manufacturing is listed as one of the top ten key remediation industries, and it is necessary to implement clean transformation, new construction, reconstruction, and expansion of the ten key remediation industry construction projects to implement equal or reduced emissions of major pollutants; ) The industry implements the green enzyme production technology transformation; at the same time, the ten articles of water classify the industrial discharged sewage, and the sewage discharge of API companies is restricted.N, N-dimetilalilamina CAS:2155-94-4 From the perspective of the overall life cycle of generic drugs from R & D to sales, with the expiration of patents, the business model for the production and marketing of generic pharmaceutical raw materials has changed, demand has increased, business potential has been realized quickly, and gross profit margins have shown a downward trend.We purchase the raw materials from raw material or chemical product manufacturers both in Japan and internationally.

Related Products
Product Name
Icatibant Acetate View Details
L-Alanine View Details
2-Bromo-5-methylpyridine View Details
Methyl Bromopyruvate manufacturer 1-[2-Amino-1-(4-methoxyphenyl)ethyl]cyclohexanol Hydrochloride manufacturer 4-chloroaniline manufacturer 3-Methyl-3-Pyrazolin-5-One manufacturer [[(1R)-2-(6-aMino-9H-purin-9-yl)-1-Methylethoxy]Methyl]-, Monophenylester manufacturer